Project Grant HT94252510857
- This federal Project Grant award of $400,814.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by the University of Illinois to develop a portable panretinal imager for automated detection of retinal detachment in austere environments. The award has a performance period from October 1, 2025 to September 30, 2028, and aims to transform healthcare for military service members, veterans, and the broader public through...
- This federal Project Grant award of $405,600.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is for a project titled "RETINAL REPAIR VIA VIRAL-MEDIATED ENDOGENOUS REPROGRAMMING OF MULLER GLIA CELLS" to be performed by the Regents of the University of Michigan from August 1, 2025 to July 31, 2027. The award supports advanced biomedical research to transform healthcare for military service members,...
- This federal Project Grant award, valued at $426,400.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of Chicago. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the general public. Specifically, the funding will enable nanoscale structural and molecular mapping of the optic nervous system following ocular blast, with the ultimate...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This federal Project Grant award for $267,544.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award, granted to the Metis Foundation, a non-profit organization based in San Antonio, Texas, will fund research on the "Therapeutic Effects of Peroxisome Proliferator-Activated Receptor Alpha...
- The Defense Health Agency awarded Duke University a $1,086,934 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop a compact, autoaligning multimodality eye imager to diagnose traumatic eye injuries. The award period runs from August 15, 2024 to August 14, 2027. Through this federal grant, Duke University will conduct research and development to create an advanced medical device that can accurately assess and diagnose traumatic eye conditions,...
- The U.S. Defense Health Agency awarded the Centre for Eye Research Australia LIMITED (operating as the University of Melbourne Department of Ophthalmology) a $1,919,965 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The 3-year grant, running from September 30, 2025 to September 29, 2028, will support a randomized clinical trial to evaluate an investigational device for retinal thermofusion as a treatment for retinal detachment without tamponade. The...
- The Department of the Army Medical Command awarded a $1,512,511 project grant to Stanford University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop a photovoltaic substitute for lost photoreceptors in retinal injury or degeneration. Through this award, Stanford University researchers will investigate medical solutions for vision impairment on the battlefield and among the general public....
- The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
- This federal Project Grant award of $872,811.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Luna Labs USA LLC, a small business manufacturer and research and development firm based in Charlottesville, Virginia. The grant supports the development of an OPTIC (Ocular Puncture Teardrop Immunoassay Cassette) system, a specialized medical technology for the U.S. military. The award period runs from August 1, 2025 to July 31,...
This federal Project Grant award for $779,173.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the development of a Portable Panretinal Imager for Automated Detection of Retinal Detachment in Austere Environments. The grant was awarded to the University of Illinois, a prominent public research institution, to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award has an ultimate completion date of September 30, 2028 and will fund innovative research to create a portable device capable of detecting retinal detachment, a critical condition that can lead to vision loss, in remote or resource-limited settings. This project aligns with the program's focus on developing medical solutions for the battlefield and addressing critical health challenges relevant to military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $779.2k | 8/7/25 |